Potential role of curcumin and taurine combination therapy on human myeloid leukemic cells propagated in vitro

Leukemia and Lymphoma

Volumn 54, Issue 10, 2013, Pages 2281-2287

  El Houseini, Motawa E ^a   Refaei, Mohammed Osman ^b   Amin, Ahmed Ibrahim ^b   Abol Ftouh, Mahmoud A ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Acute myeloid leukemia (AML); Chronic myeloid leukemia (CML); Curcumin taurine; Immunophenotypic profile; Interferon

Indexed keywords

ANTINEOPLASTIC AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CURCUMIN; GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR ALPHA; TAURINE;

ARTICLE; BLAST CELL; CELL DENSITY; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; IN VITRO STUDY; LEUKEMIA CELL; MALE; MONONUCLEAR CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; THERAPY EFFECT;

ADULT; ANTIGENS, CD4; ANTIGENS, CD8; CELL SURVIVAL; CURCUMIN; DRUG COMBINATIONS; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; TAURINE; YOUNG ADULT;

EID: 84884485421     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.776167     Document Type: Article

References (40)

1. Zander AR, Bacher U, Finke J: Allogeneic stem cell transplantation in acute myeloid leukemia. Dtsch Arztebl Int 2008; 105: 663-669.
2. Goldberg SL, Masood A. Identifying and treating imatinib failure in chronic myelogenous leukemia: A practical review of treatment guidelines and available agents. Commun Oncol 2009; 6: 113-125.
3. Sa G, Das T. Anticancer effects of curumin: Cycle of life and death. Cell Div 2008; 3: 14.
4. Jurenka JS. A nti-infl ammatory properties of curcumin, a major constituent of Curcima longa: A review of preclinical and clinical research. Altern Med Rev 2009; 14: 141-153.
5. Yogesh PP, Nayak PL. Curcumin: A wonder anticancer drug. Int J Pharm Biomed Sci 2012; 3: 60-69.
6. Yu J, Kim AK. Effect of taurine on antioxidant enzyme system in B16F10 melanoma cells. Adv Exp Med Biol. 2009; 643: 491-499.
7. Dawson T, Mandir A, Lee M. A nimal models of PD: Pieces of the same puzzle? Neuron 2002; 35: 219-222.
8. Franconi F, Coinu R, Carta S, et al. Antioxidant effect of two virgin olive oils depends on the concentration and composition of minor polar compounds. J Agric Food Chem 2006; 54: 3121-3125.
9. Shiny S, Kumar H, Farrvin H, et al. Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infaction in rats. J Pharm Pharmacol 2005; 57: 1313-1317.
10. Schuller-Levis GB, Park E. Taurine and its chloramine: Modulators of immunity. Neurochem Res 2004; 29: 117-126.
11. Petrovic L, Schlegel KA, Ries J, et al. In-vitro-effect of taurolidine on squamous cell carcinoma of the oral cavity. Oral Maxillofac Surg 2003; 7: 102-107.
12. Rodak R, Kubota H, Ishihara H, et al. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine. J Neurosurg 2005; 102: 1055-1068.
13. Klamt F, Shacter E. Taurine chloramine, an oxidant derived from neutrophils induces apoptosis in human B lymphoma cells through mitochondrial damage. J Biol Chem 2005; 280: 21346-21352.
14. Lambert H. Regulation of the cellular content of the oraganic osmolyte taurine in mammalian cells. Neurochem Res 2004; 29: 27-63.
15. Janeway CA, Travers P, Walport M, et al. Immunobiology: The immune system in health and disease. 6th ed. New York: Garland Science; 2005. pp 438-439.
16. Schoenborn JR, Wilson CB. Regulation of interferon-during innate and adaptive immune responses. Adv Immunol 2007; 96: 41-101.
17. Serre K, Mohr E, Gasapal F, et al. IL-4 directs both CD4 + and CD8 + T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo. Mol Immunol 2010; 47: 1914-1922.
18. Bui JD, Schreiber RD. Cancer immunosurveillance, immunoediting and infl ammation: Independent or interdependent processes? Curr Opin Immunol 2007; 19: 203-208.
19. Ossina NK, Cannas A, Powers VC, et al. Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosisrelated gene expression. J Biol Chem 1997; 272: 16351-16357.
20. Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, et al. Interferongamma sensitises human myeloid leukemia cells to death receptormediated apoptosis by a pleiotropic mechanism. J Biol Chem 2001; 276: 17779-17787.
21. Freshney R. Culture of animal cells: A manual of basic technique. New York: Alan R. Liss; 1987. p 117.
22. Shapiro HM. Practical fl ow cytometry. 2 nd ed. N ew York: Wiley & Sons; 1988. p 129.
23. Jedurg A, Fitting C, David B. Variable estimates of cytokine levels produced by commercial ELISA kit results using international cytokine standards. J Immunol Methods 1995; 186: 171-179.
24. Papa S. European Working Group on Clinical Cell Analysis (EWGCCA): 6 years on. J Biol Regul Homeost Agents 2002; 16: 253-256.
25. Cao J, Liu Y, Jia L, et al. Curcumin attenuates acrylamide-induced cytotoxicity and genotoxicity in HepG2 cells by ROS scavenging. J Agric Food Chem 2008; 56: 12059-12063.
26. Vareed SK, Kakarala M, Ruffin MT, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008; 17: 1411-1417.
27. Lee DS, Lee MK, Kim JH. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res 2009; 29: 5039-5044.
28. Weinitschke S, Denger K, Cook AM, et al. The DUF81 protein TauE in Cupriavidus necator H16, a sulfite exporter in the metabolism of C2 sulfonates. Microbiology 2007; 153: 3055-3060.
29. Nonaka H, Tsujino T, Watari Y, et al. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: Amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 2001; 104: 1165-1170.
30. Rao J, Xu D, Zheng F, et al. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34 + acute myeloid leukemia cell lines and primarysorted CD34 + acute myeloid leukemia cells. J Transl Med 2011; 9: 71.
31. Hashim FJ, Shawkat MS, Al-Jewari H. Cytotoxicity of curcumin against leukemic cell lines via apoptosis activity. Curr Res J Biol Sci 2012; 4: 60-64.
32. Jia YL, Li J, Qin ZH, et al. Autophagic and apoptotic mechanisms of curcumin-induced death in K562 cells. J Asian Nat Prod Res 2009; 11: 918-928.
33. Osman C, Sadettin T, Ahmet G. Protective effect of curcumin on immune system and body weight gain on rats intoxicated with 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD). Hum Exp Toxicol 2010; 32; 1.
34. Cong Y, Wang L, Konrad A, et al. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells. Eur J Immunol 2009; 39: 3134-3146.
35. Wirleitner B, Neurauter G, Nagl M, et al. Down-regulatory effect of N-chlorotaurine on tryptophan degradation and neopterin production in human PBMC. Immunol Lett 2004; 93: 143-149.
36. Mautner J, Jaffee EM, Pardoll DM. Tumor-specific CD4 + T cells from a patient with renal cell carcinoma recognize diverse shared antigens. Int J Cancer 2005; 115: 752-759.
37. Ciftci O, Tanyildizi S, Godekmerdan A. Curcumin, myrecen and cineol modulate the percentage of lymphocyte subsets altered by 2,3,7,8- tetracholorodibenzo-p-dioxins (TCDD) in rats. Hum Exp Toxicol 2011; 30: 1986-1994.
38. Luo F, Song X, Zhang Y, et al. Low-dose curcumin leads to the inhibition of tumor growth via enhancing CTL-mediated antitumor immunity. Int Immunopharmacol 2011; 11: 1234-1240.
39. Fazzino F, Obregon F, Lima L. Taurine and proliferation of lymphocytes in physically restrained rats. J Biomed Sci 2010; 24: 17.
40. Zamarron BF, Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci 2011; 7: 651-658.